| Document Date: 2009-03-31 15:45:06
Open Document File Size: 278,28 KBShare Result on Facebook
Country United States / / Currency pence / / IndustryTerm treatment for Alzheimer’s disease / food / / MedicalCondition Alzheimer's disease / probable Alzheimer’s disease / Alzheimer’s disease / Disease Assessment Scale / disease / Alzheimer's Disease Assessment Scale / very advanced disease / greater cognitive impairment / cognitive impairment / / Organization DOSAGE AND ADMINISTRATION / Concurrent administration / PRECAUTIONS / / Person Randomized Patients / / Product polyethylene glycol / Immediate-Release Tablets / fluoxetine / EXTENDED-RELEASE CAPSULES / ketoconazole / ranitidine / erythromycin / cimetidine / digoxin / galantamine hydrobromide / / Technology Pharmacokinetics / /
SocialTag |
NDA[removed]AP Label Page 4 TRADEMARK (GALANTAMINE HBR) EXTENDED-RELEASE CAPSULES